British Journal of Cancer
-
Publication Venue For
-
Effect of aerobic training on the host systemic milieu in patients with solid tumours: An exploratory correlative study.
112:825-831.
2015
-
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort..
106:1095-1099.
2012
-
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification..
106:916-922.
2012
-
Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma..
105:112-117.
2011
-
Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (British Journal of Cancer (2009) 100 (412-420) DOI: 10.1038/sj.bjc.6604820 www.bjcancer.com).
101:1805.
2009
-
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs (British Journal of Cancer (2008) 99, (294-304) DOI: 10.1038/sj.bjc.6604459).
100:1012.
2009
-
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.
100:412-420.
2009
-
Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis..
98:294-299.
2008
-
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis..
98:282-288.
2008
-
Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts..
97:735-740.
2007
-
Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy..
97:391-397.
2007
-
Regulation of mammalian horizontal gene transfer by apoptotic DNA fragmentation..
95:1696-1700.
2006
-
Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation..
95:1013-1019.
2006
-
HIF-1 and tumour radiosensitivity..
95:1-5.
2006
-
Birth weight and breast cancer risk..
94:1734-1737.
2006
-
Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis..
93:1350-1355.
2005
-
Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York..
93:699-708.
2005
-
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer..
93:195-199.
2005
-
Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery..
92:1414-1420.
2005
-
Targeted radiotherapy of brain tumours..
90:1469-1473.
2004
-
Invasion and MMP expression profile in desmoid tumours..
90:1443-1449.
2004
-
Surrogate markers in antiangiogenesis clinical trials..
89:8-14.
2003
-
Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk..
88:58-62.
2003
-
Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix..
86:274-281.
2002
-
Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)..
85:98-101.
2001
-
Transfection of the sodium iodide symporter gene for tumour targeting with radioiodine and [At-211]radioastatine.
85:24-24.
2001
-
Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists..
83:906-913.
2000
-
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse..
83:588-593.
2000
-
Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer..
83:324-328.
2000
-
Vascular permeability in a human tumour xenograft: molecular charge dependence..
82:1513-1518.
2000
-
Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features..
82:1191-1197.
2000
-
Lack of evidence for MHC-unrestricted (atypical) recognition of mucin by mucinous pancreatic tumour-reactive T-cells..
82:691-701.
2000
-
Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522..
81:1274-1279.
1999
-
Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice..
81:966-971.
1999
-
Laminin mediates tethering and spreading of colon cancer cells in physiological shear flow..
80:1927-1934.
1999
-
Bcl10 is not a target for frequent mutation in human carcinomas..
80:1575-1576.
1999
-
G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder..
80:1175-1184.
1999
-
Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia..
79:1717-1722.
1999
-
Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity..
80:87-95.
1999
-
The effects of hyperoxic and hypercarbic gases on tumour blood flow..
80:117-126.
1999
-
Progesterone receptor gene polymorphism and risk for breast and ovarian cancer..
78:277.
1998
-
Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions..
77:2061-2068.
1998
-
Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia..
77:753-759.
1998
-
Combretastatin A-4 P as a tumour vascular targeting agent.
78:48-48.
1998
-
Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis..
77:51-56.
1998
-
3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
76:226-233.
1997
-
3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells..
76:226-233.
1997
-
Effects of diethylamine/nitric oxide on blood perfusion and oxygenation in the R3230Ac mammary carcinoma..
76:429-437.
1997
-
Fluorescence ratio imaging of interstitial pH in solid tumours: effect of glucose on spatial and temporal gradients..
74:1206-1215.
1996
-
Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity..
73:1171-1177.
1996
-
Arteriolar oxygenation in tumour and subcutaneous arterioles: Effects of inspired air oxygen content.
74.
1996
-
Microvascular studies on the origins of perfusion-limited hypoxia.
74.
1996
-
The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation..
72:1120-1124.
1995
-
New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment..
72:250.
1995
-
Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcoma..
71:1181-1187.
1995
-
Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma..
71:1169-1174.
1995
-
Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma.
71:1169-1174.
1995
-
Differences in leucocyte-endothelium interactions between normal and adenocarcinoma bearing tissues in response to radiation..
69:883-889.
1994
-
The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment..
67:734-741.
1993
-
2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylation..
67:209-215.
1993
-
Genetic susceptibility to naevi--a twin study..
64:1164-1167.
1991
-
Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis..
62:637-642.
1990
-
Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer..
62:238-242.
1990
-
Double antibody radioimmunoassay for monitoring metastatic breast cancer..
58:362-367.
1988
-
B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens..
58:182-185.
1988
-
Influence of tumour size on human prostate tumour metastasis in athymic nude mice..
51:419-423.
1985
-
A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas..
51:283-289.
1985
-
C-type virus particles in human urogenital tumours after heterotransplantation into nude mice..
39:35-42.
1979
-
Inducers of Friend leukaemic cell differentiation in vitro--effects of in vivo administration..
33:634-645.
1976
-
Proceedings: Oral and pharyngeal cancers in textile workers..
32:249.
1975
-
Refusal in testicular cancer patients: implications for surveillance..
65:786.
1992
-
Enhancement of targeted radiotehrapy in neuroblastoma: A novel gene therapy approach
2004
-
Targeted radiotherapy of brain tumours
2003
-
Targets of the ABL tyrosine kinases in normal and transformed cells.
1998